| Literature DB >> 30275364 |
Zhongbin Cheng1,2, Wei Xu3, Lijun Liu4, Shumin Li5, Wangjun Yuan6,7, Zhuhua Luo8, Jingjie Zhang9, Yongjun Cheng10, Qin Li11,12.
Abstract
Chemical examination of the EtOAc extract of the deep sea-derived fungus Penicillium sp. YPGA11 resulted in the isolation of four new farnesylcyclohexenones, peniginsengins B⁻E (1⁻4), and a known analog peniginsengin A (5). The structures of compounds 1⁻4 were determined on the basis of comprehensive analyses of the nuclear magnetic resonance (NMR) and mass spectroscopy (MS) data, and the absolute configurations of 1, 2, and 4 were determined by comparisons of experimental electronic circular dichroism (ECD) with calculated ECD spectra. Compounds 1⁻5, characterized by a highly oxygenated 1-methylcyclohexene unit and a (4E,8E)-4,8-dimethyldeca-4,8-dienoic acid side chain, are rarely found in nature. Compounds 2⁻4 exhibited antibacterial activity against Staphylococcus aureus.Entities:
Keywords: Penicillium sp.; antibacterial; deep sea-derived fungus; farnesylcyclohexenones
Mesh:
Substances:
Year: 2018 PMID: 30275364 PMCID: PMC6213461 DOI: 10.3390/md16100358
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–5 from Penicillium sp.
1H and 13C nuclear magnetic resonance (NMR) data of 1 and 2 (1 in DMSO-d6 and 2 in CD3OD, δ in ppm).
| No. | 1 | 2 | ||
|---|---|---|---|---|
| δH
a (Mult, | δC b, Type | δH
c (Mult, | δC d, Type | |
| 1 | 199.6, C | 201.4, C | ||
| 2 | 77.1, C | 2.43, ddd (10.2, 3.8, 2.3) | 53.4, CH | |
| 3 | 2.87, d (15.9) | 49.5, CH2 | 4.20, dd (3.0, 2.3) | 73.7, CH |
| 4 | 197.1, C | 4.44, br s | 73.3, CH | |
| 5 | 150.3, C | 162.4, C | ||
| 6 | 6.69, d (1.34) | 135.7, CH | 5.84, br s | 126.8, CH |
| 7 | 1.89, d (1.34) | 15.5, CH3 | 2.02, br s | 20.3, CH3 |
| 1′ | 2.35, dd (14.0, 7.4) | 36.8, CH2 | 2.25, m | 24.4, CH2 |
| 2′ | 5.02, t (7.4) | 118.4, CH | 5.17, t (6.9) | 123.2, CH |
| 3′ | 138.1, C | 138.1, C | ||
| 4′ | 1.93, m | 39.5, CH2 | 2.05, m | 40.7, CH2 |
| 5′ | 1.99, m | 25.8, CH2 | 2.13, m | 27.5, CH2 |
| 6′ | 5.06, t (6.60) | 123.9, CH | 5.16, t (5.9) | 125.9, CH |
| 7′ | 133.7 C | 134.7, C | ||
| 8′ | 2.15, m | 34.2, CH2 | 2.27, m | 35.7, CH2 |
| 9′ | 2.24, m | 32.7, CH2 | 2.38, m | 34.0, CH2 |
| 10′ | 174.2, C | 177.4, C | ||
| 11′ | 1.55, s | 15.8, CH3 | 1.63, s | 16.1, CH3 |
| 12′ | 1.48, s | 16.0, CH3 | 1.66, s | 16.2, CH3 |
a Recorded at 400 MHz, b Recorded at 100 MHz, c Recorded at 600 MHz, d Recorded at 150 MHz.
Figure 2Key correlation spectroscopy (COSY), heteronuclear multiple bond correlation (HMBC), and nuclear Overhauser effect (NOE) correlations of 1–4.
Figure 3Experimental and calculated electronic circular dichroism (ECD) spectra of 1.
Figure 4Experimental and calculated ECD spectra of 2.
1H and 13C NMR data of 3 and 4 (CD3OD, δ in ppm).
| No. | 3 | 4 | ||
|---|---|---|---|---|
| δH
a (Mult, | δC b, Type | δH
a (Mult, | δC b, Type | |
| 1 | 4.18, m | 67.2, CH | 194.9, C | |
| 2 | 63.8, C | 61.3, C | ||
| 3 | 3.31, m | 61.4, CH | 3.70, d (2.6) | 57.5, CH |
| 4 | 4.19, m | 68.3, CH | 5.85, d (2.6) | 70.3, CH |
| 5 | 134.9, C | 154.5, C | ||
| 6 | 5.23, m | 124.9, CH | 5.83, br s | 125.4, CH |
| 7 | 1.75, s | 19.2, CH3 | 1.89, br s | 19.8, CH3 |
| 1′ | 2.90, d (14.6, 8.9) | 32.1, CH2 | 2.74, dd (15.2, 7.9) | 27.0, CH2 |
| 2′ | 5.14, m | 119.6, CH | 5.03, dd (7.9, 6.8) | 118.0, CH |
| 3′ | 139.8 C | 140.4, C | ||
| 4′ | 2.06, m | 40.7, CH2 | 2.02, m | 40.6, CH2 |
| 5′ | 2.13, m | 27.2, CH2 | 2.09, m | 27.2, CH2 |
| 6′ | 5.13, m | 125.7, CH | 5.12, dd (7.7, 6.9) | 125.6, CH |
| 7′ | 135.0, C | 135.1, C | ||
| 8′ | 2.25, t (7.7) | 35.9, CH2 | 2.25, m | 36.0, CH2 |
| 9′ | 2.35, t (7.7) | 34.3, CH2 | 2.35, m | 34.5, CH2 |
| 10′ | 177.7, C | 177.8, C | ||
| 11′ | 1.67, s | 16.4, CH3 | 1.64, s | 16.4, CH3 |
| 12′ | 1.62, s | 16.1, CH3 | 1.62, s | 16.1, CH3 |
| 1-OAc | 2.20, s | 20.6, CH3 | ||
a 1H NMR recorded at 600 MHz, b 13C NMR recorded at 150 MHz.
Figure 5Experimental and calculated ECD spectra of 4 and 5.
Antibacterial activity of 1–4.
| No. | MIC (μg/mL) | |
|---|---|---|
|
| >128 | >128 |
|
| 8 | 32 |
|
| 16 | >128 |
|
| 32 | 64 |
| Penicillin a | <0.5 | >128 |
| Vancomycin a | − b | <0.5 |
a Positive control. b Not tested